搜索表单

您现在的位置:首页  > 新闻聚焦 > 本院动态

白泽专栏

一周免疫报 更多>>

白泽讲坛 | Michael Karin:癌症免疫治疗现状

stdClass Object ( [vid] => 2231 [uid] => 1848 [title] => 白泽讲坛 | Michael Karin:癌症免疫治疗现状 [log] => [status] => 1 [comment] => 1 [promote] => 0 [sticky] => 0 [nid] => 2231 [type] => article [language] => zh-hans [created] => 1572417088 [changed] => 1572417088 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1572417088 [revision_uid] => 1848 [body] => Array ( [und] => Array ( [0] => Array ( [value] => [summary] => [format] => full_html [safe_value] => [safe_summary] => ) ) ) [field_tags] => Array ( [und] => Array ( [0] => Array ( [tid] => 70 ) ) ) [field_image] => Array ( ) [field_titleimage] => Array ( [und] => Array ( [0] => Array ( [fid] => 43 [uid] => 1 [filename] => news_file.png [uri] => public://default_images/news_file.png [filemime] => image/png [filesize] => 145136 [status] => 1 [timestamp] => 1428861916 [origname] => news_file.png [rdf_mapping] => Array ( ) [is_default] => 1 [alt] => [title] => ) ) ) [field_attach] => Array ( ) [field_display_index] => Array ( [und] => Array ( [0] => Array ( [value] => 0 ) ) ) [metatags] => Array ( [zh-hans] => Array ( [title] => Array ( [value] => [node:title] | [current-page:pager][site:name]白泽讲坛 | 美国科学院院士Michael Karin:癌症免疫治疗现状 ) [description] => Array ( [value] => [node:summary]2019年4月24日,Michael Karin教授也为我们带来了精彩的讲座的——《癌症免疫治疗:现状以及未来发展方向(CANCER IMMUNOTHERAPY : Current state of affairs and future directions)》,由浅至深的为我们讲解了人体免疫系统与癌症治疗之间的关系,并分享当今主流的两种免疫疗法:免疫检查点抑制剂以及过继性细胞疗法的作用机制,用独特的角度分析了免疫疗法的临床数据及未来趋势。同时在讲座结束之后也参观了上海细胞治疗集团乘黄纳米抗体研发中心,详细的了解了纳米抗体在免疫治疗中的应用。 ) [abstract] => Array ( [value] => Michael Karin教授也为我们带来了精彩的讲座的——《癌症免疫治疗:现状以及未来发展方向(CANCER IMMUNOTHERAPY : Current state of affairs and future directions)》,由浅至深的为我们讲解了人体免疫系统与癌症治疗之间的关系,并分享当今主流的两种免疫疗法:免疫检查点抑制剂以及过继性细胞疗法的作用机制,用独特的角度分析了免疫疗法的临床数据及未来趋势。同时在讲座结束之后也参观了上海细胞治疗集团乘黄纳米抗体研发中心,详细的了解了纳米抗体在免疫治疗中的应用。 ) [keywords] => Array ( [value] => 上海细胞治疗研究院,白泽计划,免疫治疗,癌症,白泽讲坛,Michael Karin ) ) ) [rdf_mapping] => Array ( [field_image] => Array ( [predicates] => Array ( [0] => og:image [1] => rdfs:seeAlso ) [type] => rel ) [field_tags] => Array ( [predicates] => Array ( [0] => dc:subject ) [type] => rel ) [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1572417088 [last_comment_name] => [last_comment_uid] => 1848 [comment_count] => 0 [domains] => Array ( [4] => 4 ) [domain_site] => 1 [subdomains] => Array ( [0] => All affiliates [1] => 管理后台 ) [name] => wangjiani [picture] => 0 [data] => a:5:{s:16:"ckeditor_default";s:1:"t";s:20:"ckeditor_show_toggle";s:1:"t";s:14:"ckeditor_width";s:4:"100%";s:13:"ckeditor_lang";s:2:"en";s:18:"ckeditor_auto_lang";s:1:"t";} [entity_view_prepared] => 1 )